Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative Colitis

Clinical Gastroenterology and Hepatology

Volumn 15, Issue 2, 2017, Pages 240-246.e1

  Gubatan, John ^a   Mitsuhashi, Shuji ^a   Zenlea, Talia ^a   Rosenberg, Laura ^a   Robson, Simon ^a   Moss, Alan C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Biomarker; IBD; Relapse Prevention

Indexed keywords

25 HYDROXYVITAMIN D; AZATHIOPRINE; CORTICOSTEROID; MERCAPTOPURINE; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR INHIBITOR; VITAMIN D;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; COLONOSCOPY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE RISK; RELAPSE; REMISSION; SENSITIVITY AND SPECIFICITY; TERTIARY HEALTH CARE; ULCERATIVE COLITIS; VITAMIN BLOOD LEVEL; AGED; BLOOD; CHEMISTRY; COLITIS, ULCERATIVE; COLON; PATHOLOGY; RECURRENT DISEASE; RISK ASSESSMENT; SERUM; TERTIARY CARE CENTER; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; COLITIS, ULCERATIVE; COLON; COLONOSCOPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; SERUM; TERTIARY CARE CENTERS; VITAMIN D;

EID: 85008689615     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2016.05.035     Document Type: Article

References (32)

1. 1 Zhang, Y.-Z., Li, Y.-Y., Inflammatory bowel disease: pathogenesis. World J Gastroenterol 20 (2014), 91–99.
2. 2 Xavier, R.J., Podolsky, D.K., Unravelling the pathogenesis of inflammatory bowel disease. Nature 207 (2007), 427–434.
3. 3 Cantorna, M.T., Mahon, B.D., Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med 229 (2004), 1136–1142.
4. 4 Mouli, V.P., Ananthakrishnan, A.N., Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther 39 (2014), 125–136.
5. 5 Ooi, J.H., Chen, K., Cantorna, M.T., Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors?. Mol Aspects Med 33 (2012), 77–82.
6. 6 Kongsbak, M., Levring, T.B., Geisler, C., et al. The vitamin D receptor and T cell function. Front Immunol, 4, 2013, 148.
7. 7 Sloka, S., Silva, C., Wang, J., et al. Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism. J Neuroinflammation 8 (2011), 56–66.
8. 8 Adorini, L., Penna, G., Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handb Exp Pharmacol 188 (2009), 251–273.
9. 9 Piemonti, L., Monti, P., Sironi, M., et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 164 (2000), 4443–4451.
10. 10 Cantorna, M.T., Snyder, L., Lin, Y.D., et al. Vitamin D and 1, 25 (OH) 2D regulation of T cells. Nutrients 7 (2015), 3011–3021.
11. 11 Smolders, J., Thewissen, M., Peelen, E., et al. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One, 4, 2009, e6635.
12. 12 Liu, P.T., Stenger, S., Li, H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 (2006), 1770–1773.
13. 13 Liu, W., Chen, Y., Golan, M.A., et al. Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J Clin Invest 123 (2013), 3983–3996.
14. 14 Xia, S.-L., Yu, L.Q., Chen, H., et al. Association of vitamin D receptor gene polymorphisms with the susceptibility to ulcerative colitis in patients from Southeast China. J Recept Signal Transduct Res 35 (2015), 530–535.
15. 15 Simmons, J.D., Mullighan, C., Welsh, K.I., et al. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 47 (2000), 211–214.
16. 16 Froicu, M., Weaver, V., Wynn, T.A., et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17 (2003), 2386–2392.
17. 17 Torki, M., Gholamrezaei, A., Mirbagher, L., et al. Vitamin D deficiency associated with disease activity in patients with inflammatory bowel diseases. Dig Dis Sci 60 (2015), 1–7.
18. 18 Blanck, S., Aberra, F., Vitamin D deficiency is associated with ulcerative colitis disease activity. Dig Dis Sci 58 (2013), 1698–1702.
19. 19 Ulitsky, A., Ananthakrishnan, A.N., Naik, A., et al. Vitamin D deficiency in patients with inflammatory bowel disease association with disease activity and quality of life. JPEN J Parenter Enteral Nutr 35 (2011), 308–316.
20. 20 Ananthakrishnan, A.N., Khalili, H., Higuchi, L.M., et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 142 (2012), 482–489.
21. 21 Ananthakrishnan, A.N., Cagan, A., Gainer, V.S., et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease. Inflamm Bowel Dis, 19, 2013, 1921.
22. 22 Ham, M., Longhi, M.S., Lahiff, C., et al. Vitamin D levels in adults with Crohn's disease are responsive to disease activity and treatment. Inflamm Bowel Dis, 20, 2014, 856.
23. 23 Yang, L., Weaver, V., Smith, J.P., et al. Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patients. Clin Transl Gastroenterol, 4, 2013, e33.
24. 24 Jørgensen, S.P., Agnholt, J., Glerup, H., et al. Clinical trial: vitamin D3 treatment in Crohn's disease–a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 32 (2010), 377–383.
25. 25 Walmsley, R.S., Ayres, R.C., Pounder, R.E., et al. A simple clinical colitis activity index. Gut 43 (1998), 29–32.
26. 26 Higgins, P.D.R., Schwartz, M., Mapili, J., et al. Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut 54 (2005), 782–788.
27. 27 Turner, D., Seow, C.H., Greenberg, G.R., et al. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis. Clin Gastroenterol Hepatol 7 (2009), 1081–1088.
28. 28 Geboes, K., Riddell, R., Ost, A., et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47 (2000), 404–409.
29. 29 Frøslie, K.F., Jahnsen, J., Moum, B.A., et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 133 (2007), 412–422.
30. 30 Bessissow, T., Lemmens, B., Ferrante, M., et al. Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing. Am J Gastroenterol 107 (2012), 1684–1692.
31. 31 Hlavaty, T., Krajcovicova, A., Koller, T., et al. Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases. World J Gastroenterol 20 (2014), 15787–15796.
32. 32 Jorde, R., Sneve, M., Hutchinson, M., et al. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 171 (2010), 903–908.